Stock 603309 WELL LEAD MEDICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Well Lead Medical Co., Ltd.

Equities

603309

CNE1000021C2

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 27/06/2024 BST 		5-day change 1st Jan Change
11.01 CNY +2.32% Intraday chart for Well Lead Medical Co., Ltd. -2.22% -22.63%
06-24 Well Lead Medical Co., Ltd.(XSSC:603309) dropped from S&P Global BMI Index CI
06-12 Well Lead Medical Gets US FDA Nod for Foley Catheter MT

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 5,861 4,172 3,228 - -
Enterprise Value (EV) 1 5,861 4,172 3,228 3,228 3,228
P/E ratio 35.1 x 21.6 x 13.3 x 10.9 x 9.33 x
Yield - 3.51% 2.45% 3% 3.45%
Capitalization / Revenue - 3.01 x 1.86 x 1.55 x 1.33 x
EV / Revenue - 3.01 x 1.86 x 1.55 x 1.33 x
EV / EBITDA - - 6.95 x 6.05 x 5.51 x
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book - 2.3 x 1.63 x 1.48 x 1.34 x
Nbr of stocks (in thousands) 293,322 293,160 293,160 - -
Reference price 2 19.98 14.23 11.01 11.01 11.01
Announcement Date 19/04/23 18/04/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 1,388 1,736 2,084 2,430
EBITDA 1 - - 464.6 533.9 585.3
EBIT 1 - 238.8 301.5 368.6 428.6
Operating Margin - 17.21% 17.37% 17.69% 17.64%
Earnings before Tax (EBT) 1 - 237.3 300.1 367.2 427.1
Net income 1 166.6 192.5 242.9 297.2 345.8
Net margin - 13.87% 13.99% 14.26% 14.23%
EPS 2 0.5700 0.6600 0.8300 1.010 1.180
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share 2 - 0.5000 0.2700 0.3300 0.3800
Announcement Date 19/04/23 18/04/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - 10.9% 12.3% 13.6% 14.3%
ROA (Net income/ Total Assets) - 7.39% 8.91% 10% 10.7%
Assets 1 - 2,605 2,726 2,966 3,247
Book Value Per Share 2 - 6.200 6.760 7.440 8.240
Cash Flow per Share 2 - 0.7600 1.380 1.610 1.760
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 19/04/23 18/04/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Well Lead Medical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
11.01
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
WELL LEAD MEDICAL CO., LTD. Stock Well Lead Medical Co., Ltd.
-22.63% 444M
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.56% 181B
MEDTRONIC PLC Stock Medtronic plc
-5.44% 101B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.76% 67.54B
DEXCOM, INC. Stock DexCom, Inc.
-9.00% 45.09B
CENCORA, INC. Stock Cencora, Inc.
+9.19% 44.37B
HOYA CORPORATION Stock Hoya Corporation
+5.36% 40.7B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+13.94% 29.85B
TERUMO CORPORATION Stock Terumo Corporation
+10.26% 24.49B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-7.19% 23.99B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 603309 Stock
  4. Financials Well Lead Medical Co., Ltd.